Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil Nicotrol, SmithKline Nicoderm transdermal nicotine patches OK for OTC switch -- FDA cmte..

Executive Summary

NICOTROL AND NICODERM PATCHES UNANIMOUSLY RECOMMENDED FOR OTC USE on April 19 by FDA's Nonprescription Drugs Advisory Committee and members of the agency's Drug Abuse Advisory Committee. The committee voted 9-0 that McNeil Consumer Products' Nicotrol and SmithKline Beecham's Nicoderm nicotine transdermal patches are safe and effective for over-the-counter use as smoking cessation aids.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS028034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel